VOLUME 32: NO. 4 APRIL 2005
Editorials
Everyone Has the Right to Work

A. Boonen ......... 571
Patient Questionnaires for Clinical Research and Improved Standard Patient Care: Is It Better to
Have 80% of the Information in 100% of Patients
or 100% of the Information in 5% of Patients?

T. Pincus, F. Wolfe ......... 575
Biochemical Markers for Osteoarthritis: From the Present to the
Future and Back to the Past

T.
Anastassiades, K. Rees-Milton 578
Looking Out for the Backside!

A.C. Gelber ......... 580
Articles
Expanding the Definition of Clinical Differences: From Minimally Clinically Important Differences to Really Important Differences. Analyses in 8931 Patients with RA

F. Wolfe, K. Michaud, V. Strand ......... 583
Physical Function and Health Related Quality
of Life: Analysis of 2-Year Data from Randomized, Controlled Studies of Leflunomide, Sulfasalazine, or Methotrexate in Patients with Active RA

V. Strand, D.L. Scott, P. Emery, J.R. Kalden,
J.S. Smolen, G.W. Cannon ......... 590
A Pilot Study to Determine Whether Disability and Disease Activity Are Different in African-American and Caucasian Patients with RA in St. Louis, Missouri, USA

U.T. Iren, M.S. Walker, E. Hochman, R. Brasington ......... 602
Tuberculosis in SLE in an Endemic Area and the
Role of Isoniazid Prophylaxis During Corticosteroid Therapy

M.Y. Mok, Y. Lo, T.M. Chan,
W.S. Wong, C.S. Lau ......... 609
Effects of Prasterone on BMD in Women with SLE Receiving Chronic Glucocorticoid Therapy

P.J. Mease, E.M. Ginzler, O.S. Gluck, et al ......... 616
Antiphospholipid Antibody Profiles and Their
Clinical Associations in Chinese Patients with SLE

M.Y. Mok, E.Y.T. Chan, D.Y.T. Fong, K.F.S. Leung,
W.S. Wong, C.S. Lau ......... 622
Anti-Lipoprotein Lipase Antibody in SSc: Association with Elevated Serum Triglyceride Concentrations

M. Kodera, I. Hayakawa, K. Komura, et al ......... 629
Increased Incidence of Carcinoma of the Tongue in Patients with SSc

C.T. Derk, M. Rasheed, J.R. Spiegel,
S.A. Jimenez ......... 637
Surgery of the Hand in Patients with SSc:
Outcomes and Considerations

E.R. Bogoch, D.K. Gross ......... 642
Kidney Disease Other than Renal Crisis in Patients with Diffuse Scleroderma

V.D. Steen, A. Syzd,
J.P. Johnson, A. Greenberg, T.A. Medsger Jr ......... 649
Effect of GM-CSF on Extracellular Matrix
Deposition by Dermal Fibroblasts from Patients
with Scleroderma

L. Postiglione, P. Ladogana,
S. Montagnani, et al ......... 656
Perinatal Characteristics and Risk of Developing Primary SS: A Case-Control Study

B. Mostafavi,
S. Akyuz, M.E. Jacobsson, L.V. Nilsen, E. Theander,
L.T.H. Jacobsson ......... 665
Computer-Administered Bath AS and Quebec Scale Outcome Questionnaires for Low Back Pain: Agreement with Traditional Paper Format

H. Bent, C.R. Ratzlaff, E.C. Goligher,
J.A. Kopec, J.H. Gillies ......... 669
Older Adults' Knowledge and Beliefs About Osteoporosis: Results of Semistructured Interviews Used for the Development of Educational Materials

M. Burgener, M. Arnold, J.N. Katz, et al ......... 673
Birthweight, Vitamin D Receptor Gene Polymorphism, and Risk of Lumbar Spine OA

K.M. Jordan,
H. Syddall, E.M. Dennison, C. Cooper, N.K. Arden ......... 678
Diagnosing Hypovitaminosis D: Serum Measurements of Calcium, Phosphate, and Alkaline Phosphatase Are Unreliable, Even in the Presence
of Secondary Hyperparathyroidism

G.R. Smith, P.O. Collinson, P.D.W. Kiely ......... 684
Inhibitors of Hyaluronan Export Prevent
Proteoglycan Loss from Osteoarthritic Cartilage

P. Prehm ......... 690
Cross-sectional Association of 10 Molecular Markers of Bone, Cartilage, and Synovium with Disease Activity and Radiological Joint Damage in Patients with Hip OA: The ECHODIAH Cohort

P. Garnero, B. Mazières, A. Guéguen, et al ......... 697
Leukotriene and Prostaglandin Synthesis
Pathways in Osteoarthritic Synovial Membranes: Regulating Factors for IL-1ß Synthesis

P. Marcouiller, J-P. Pelletier, M. Guévremont, et al ......... 704
Interface Tissue Fibroblasts from Loose Total Hip Replacement Prosthesis Produce RANKL, Osteoprotegerin, and Cathepsin K

J. Mandelin, T-F. Li, M. Hukkanen, et al ......... 713
Employment Across Chronic Inflammatory
Rheumatic Diseases and Comparison with the General Population

W. Mau, J. Listing, D. Huscher,
H. Zeidler, A. Zink ......... 721
Pediatric Rheumatology
BMD in Children and Adolescents with SLE, JDM,
and Systemic Vasculitis: Relationship to Disease Duration, Cumulative Corticosteroid Dose,
Calcium Intake, and Exercise

K.A. Alsufyani, O. Ortiz-Alvarez, D.A. Cabral et al ......... 729
The Reliability of an Aerobic and an Anaerobic Exercise Tolerance Test in Patients with Juvenile Onset DM

T. Takken, J. van der Net, P.J.M. Helders ......... 734
Proliferative Lupus Nephritis and Leukocytoclastic Vasculitis During Treatment with Etanercept

A. Mor, C.O. Bingham III, L. Barisoni, E. Lydon,
H.M. Belmont ......... 740
A Child with DM and a Suspicious Lymphadenopathy

G. Martini, F. Calabrese, F. Biscaro, F. Zulian ......... 744
Intrafamilial Variable Phenotypic Expression of a CIAS1 Mutation: From Muckle-Wells to Chronic Infantile Neurological Cutaneous and Articular Syndrome

V. Hentgen, V. Despert, A-C. Leprêtre, et al ......... 747
Case Reports
Development of Crohn's Disease in a Patient Taking Etanercept

J. Oh, D.G. Arkfeld, D.A. Horwitz 752
Reversing Myocardial Microvascular Disease in a Patient with RA

K. Raza, M. Banks, G.D. Kitas .........754
Isaacs' Syndrome (Autoimmune Neuromyotonia)
in a Patient with SLE

P.W. Taylor ......... 757
Correspondence
Successful Treatment of Rheumatoid Vasculitis-Associated Foot-drop with Infliximab

D.J. Armstrong, M.T. McCarron, G.D. Wright ......... 759
Successful Treatment of Rheumatoid Vasculitis-Associated Foot-drop with Infliximab: Reply

P. Richette, T. Bardin ......... 759
Letter
Infliximab Induced Chilblain Lupus in a Patient with RA
C. Richez, C. Dumoulin, T. Schaeverbeke ......... 760
Book Review
Soft Tissue Rheumatology ......... 761
Meetings in Rheumatology